Drug Strategy Blocks a Leading Driver of Cancer
November 20, 2013
The protein in cells that most often drives the development of cancers has eluded scientists' efforts to block it for three decades – until now.
November 20, 2013
The protein in cells that most often drives the development of cancers has eluded scientists' efforts to block it for three decades – until now.
November 15, 2013
What a pathologist looks for in a Pap test sample, but hopes not to find, are oddly shaped cells with abnormally large nuclei. The same is true for prostate and lung cancer biopsies. In fact, most cancer cells display distorted structures.
November 15, 2013
Which would you choose if you were diagnosed with early-stage breast cancer? You could receive a standard chemo regimen, followed three months later by an MRI scan to determine the treatment's success. Or, instead, a genomic analysis of your biopsied breast tissue could help determine a drug regimen tailored to your own genetic makeup.
November 15, 2013
If biology is destiny, then the slightest change in a gene's DNA can become an agent of destiny.
November 14, 2013
With inexpensive genetics kits flooding the market, both consumers – and their doctors – still lack basic information about what to do, if anything, with what they learn about their own genomes.
November 11, 2013
UC San Francisco scientists report that they were able to arrest, and even reverse, tissue scarring of the liver, kidneys and lungs in mice.
Copyright © 2013-2014 University of California Regents. All Rights Reserved.
UCSF Helen Diller Family Comprehensive Cancer Center
Site Map | Terms of Use & Privacy Policy | Contact Webmaster
Subscribe to RSS